Cite
HARVARD Citation
Fukuda, K. et al. (2021). Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer. Cancer science. 112 (9), pp. 3784-3795. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fukuda, K. et al. (2021). Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer. Cancer science. 112 (9), pp. 3784-3795. [Online].